- 米国企業
- DR REDDYS LABORATORIES LTD
DR REDDYS LABORATORIES LTDRDY
時価総額
PER
2019年 3月31日 | 2020年 3月31日 | 2021年 3月31日 | 2022年 3月31日 | 2023年 3月31日 | |
Revenue | 2,225 | 2,316 | 2,594 | 2,826 | 2,992 |
Cost of sales | 1,018 | 1,069 | 1,185 | 1,325 | 1,296 |
Gross profit | 1,206 | 1,247 | 1,409 | 1,500 | 1,695 |
Selling, General and Administrative Expense | 707 | 665 | 747 | 818 | 828 |
Research and Development Expense | 226 | 204 | 226 | 230 | 236 |
Impairment of non-current assets | - | 222 | 117 | 100 | 9 |
Other income, net | 28 | 57 | 13 | 36 | 72 |
Total operating expenses | 904 | 1,035 | 1,077 | 1,112 | 1,000 |
Results from operating activities (A) | 302 | 212 | 332 | 389 | 695 |
Finance income | 33 | 33 | 36 | 41 | 52 |
Finance expense | 17 | 13 | 13 | 13 | 17 |
Finance income, net (B) | 16 | 20 | 23 | 28 | 35 |
Share of profit of equity accounted investees, net of tax (C) | 6 | 7 | 7 | 9 | 5 |
Profit before tax | 325 | 239 | 361 | 426 | 734 |
Tax expense, net | 53 | -19 | 125 | 115 | 186 |
Profit for the year | 272 | 259 | 236 | 311 | 548 |
Basic earnings (loss) per share | 1.64 | 1.56 | 1.42 | 1.87 | 3.3 |
Diluted earnings (loss) per share | 1.64 | 1.56 | 1.52 | 1.87 | 3.3 |